Chief Financial Officer
Immuno Chemistry Technologies, LLC
Howard Horn is the Chief Financial Officer of Vir. Previously, he was the head of the Financial Planning (FP&A) and Corporate Finance functions at Biogen where he led the company’s resource and capital allocation processes across all functions and regions.
Prior to joining Biogen, Howard held positions of increasing responsibility as a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Company and as an equity research analyst in the Life Sciences group at UBS. Howard also co-founded NOBLE.MD, a technology-based startup focused on improving health outcomes.